Our Company
Onc.AI is a privately held digital health company on a mission to radically improve oncology decision making
By leveraging a market-leading oncology real-world dataset (diagnostic imaging, EMR, labs, genomics), Onc.AI is developing a pipeline of AI models to fulfill the potential of precision oncology. Our first product will help medical oncologists make treatment decisions for metastatic lung cancer patients treated with PD-1 immunotherapy.